The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2004
Filed:
Jan. 18, 2002
Stanley D. Glick, Delmar, NY (US);
Isabelle M. Maisonneuve, Delmar, NY (US);
Albany Medical College, Albany, NY (US);
Abstract
A method for treating an addiction disorder (such as an addiction to or dependency on stimulants, nicotine, morphine, heroin, other opiates, amphetamines, cocaine, and/or alcohol) in a patient is disclosed. The method includes administering to the patient a first &agr; &bgr; nicotinic receptor antagonist and administering to the patient a second &agr; &bgr; nicotinic receptor antagonist. The second &agr; &bgr; nicotinic receptor antagonist is different than the first &agr; &bgr; nicotinic receptor antagonist, and the first &agr; &bgr; nicotinic receptor antagonist and the second &agr; &bgr; nicotinic receptor antagonist are administered simultaneously or non-simultaneously. Compositions which include a first &agr; &bgr; nicotinic receptor antagonist and a second &agr; &bgr; nicotinic receptor antagonist are also described. Examples of suitable &agr; &bgr; nicotinic receptor antagonists for use in the present invention's methods and compositions include mecamylamine, 18-methoxycoronaridine, bupropion, dextromethorphan, dextrorphan, and phamaceutically acceptable salts and solvates thereof. A method of evaluating a compound for its effectiveness in treating addiction disorders is also described.